Serum anti-mullerian hormone levels and age among Samoan women
Open Access
- 19 March 2025
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 23 (1) , 1-8
Abstract
Background: Serum AMH levels in adult women are part of the diagnostic criteria for polycystic ovary syndrome (PCOS), a condition with marked infertility and metabolic risks. Yet, little is known about AMH levels among women from ethnic minority populations, especially its associations with age and obesity. The objective is to describe the association of age and serum anti-mullerian hormone (AMH) among Samoan women, provide age specific AMH reference levels, and examine the associations of AMH with adiposity and reproductive factors. Methods: A cross-sectional, retrospective study of a representative community-based sample from Samoa was conducted. 670 women with no known reproductive disorders, reproductive surgeries, or hormonal contraceptive use, age 25–51 years, were included. Adiposity was assessed by body mass index (BMI) using Polynesian-specific criteria for obesity. Serum AMH was determined by enzyme-linked immunosorbent assay. Serum total testosterone and sex hormone binding globulin were measured, and the free androgen index was calculated. Hormonal contraceptive use, menstrual regularity, and tobacco use were assessed by questionnaire. PCOS prevalence was estimated using current guidelines. Results: Despite a high prevalence of obesity and overweight in Samoan women, serum AMH and its age related decline were similar to those reported in other populations. AMH was negatively associated with age. AMH decline with age in Samoan women is best described by a cubic model. AMH was not associated with BMI or insulin resistance. PCOS prevalence was estimated at 3.4–5.1%. Conclusion: This study was the first to construct an age specific AMH reference range for Samoan women. PCOS prevalence appears low, supporting other published studies that have demonstrated a complex relationship between adiposity and reproductive health in Samoan women. Clinical trial number: Not applicable.Keywords
Funding Information
- National Institutes of Health (R01 HL093093 (STM) andT35 DK065521 (MA), R01 HL093093 (STM) andT35 DK065521 (MA))
This publication has 35 references indexed in Scilit:
- Racial and ethnic disparities in polycystic ovary syndromeFertility and Sterility, 2023
- Reproductive health, obesity, and cardiometabolic risk factors among Samoan womenAmerican Journal of Human Biology, 2018
- Criteria, prevalence, and phenotypes of polycystic ovary syndromeFertility and Sterility, 2016
- Cut-off levels for hyperandrogenemia among Samoan women: An improved methodology for deriving normative data in an obese populationClinical Biochemistry, 2016
- Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in polycystic ovary syndromeClinica Chimica Acta, 2015
- Prevalence of adiposity and associated cardiometabolic risk factors in the samoan genome‐wide association studyAmerican Journal of Human Biology, 2014
- Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling womenFertility and Sterility, 2014
- Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive historyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2012
- Variations in serum müllerian inhibiting substance between white, black, and Hispanic womenFertility and Sterility, 2009
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985